Benign acute childhood myositis: Factors associated with muscle symptoms and resolution

Betül Öztürk1, Aytaç Göktuğ1, İlknur Bodur1

  • 1Department of Pediatric Emergency, University of Health Sciences, Dr Sami Ulus Maternity and Children's Education and Research Hospital, Ankara, Turkey.

Abstract

Insights

Benign acute childhood myositis (BACM) symptoms resolved faster in children with influenza. Oseltamivir treatment did not impact symptom duration for BACM in children, regardless of influenza status.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Benign acute childhood myositis (BACM) is a common, self-limiting condition often linked to viral infections.
  • Understanding the specific viral triggers and treatment efficacy is crucial for pediatric care.

Purpose of the Study:

  • To compare symptom progression, laboratory findings, and the effect of oseltamivir in children with influenza-associated versus non-influenza-associated BACM.
  • To evaluate the clinical course of BACM in relation to influenza infection status.

Main Methods:

  • Retrospective analysis of 94 pediatric patients (0-18 years) presenting with BACM symptoms during influenza seasons (2018-2020).
  • Patients were categorized based on rapid influenza diagnostic test results (Influenza A, Influenza B, or negative).
  • Comparison of time to symptom resolution, laboratory markers (creatine phosphokinase, hemoglobin, platelets, white blood cell count), and oseltamivir treatment outcomes between groups.

Main Results:

  • Influenza-positive patients (n=48) showed a significantly shorter time to symptom resolution (2.9 days) compared to influenza-negative patients (n=46, 3.5 days; P=0.027).
  • Oseltamivir treatment did not alter symptom resolution duration in influenza-positive BACM cases.
  • Elevated creatine phosphokinase and leukopenia were common findings; no recurrences or metabolic diseases were reported.

Conclusions:

  • BACM symptoms tend to resolve more rapidly in children with concurrent influenza infections.
  • Oseltamivir treatment does not appear to shorten the duration of symptoms in pediatric BACM, even when associated with influenza.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.5K